Hap Trading, LLC Sarepta Therapeutics, Inc. Put Options Transaction History

Hap Trading, LLC

15 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2023 May 12, 2023	BUY	$117.53 - $155.99 $6.1 Million - $8.1 Million	51,900 New	51,900 $60,000
Q4 2021 Feb 14, 2022	SELL	$77.28 - $99.42 $378,672 - $487,158	-4,900 Reduced 30.82%	11,000 $102,000
Q3 2021 Nov 10, 2021	SELL	$65.97 - $92.48 $85,761 - $120,224	-1,300 Reduced 7.56%	15,900 $105,000
Q1 2021 May 14, 2021	SELL	$72.25 - $168.95 $296,225 - $692,695	-4,100 Reduced 19.25%	17,200 $208,000
Q4 2020 Feb 16, 2021	BUY	$125.56 - $178.74 $1.23 Million - $1.75 Million	9,800 Added 85.22%	21,300 $193,000
Q3 2020 Nov 13, 2020	SELL	$127.12 - $172.34 $101,696 - $137,872	-800 Reduced 6.5%	11,500 $125,000
Q2 2020 Aug 10, 2020	BUY	$93.0 - $171.7 $1.14 Million - $2.11 Million	12,300 New	12,300 $51,000
Q1 2020 May 08, 2020	SELL	$82.38 - $131.64 $1.85 Million - $2.96 Million	-22,500 Closed	0 $0
Q4 2019 Feb 11, 2020	BUY	$76.53 - $135.58 $864,789 - $1.53 Million	11,300 Added 100.89%	22,500 $54,000
Q3 2019 Nov 12, 2019	SELL	$72.81 - $156.91 $15.4 Million - $33.1 Million	-211,000 Reduced 94.96%	11,200 $243,000
Q2 2019 Aug 14, 2019	BUY	$112.21 - $151.95 $23.4 Million - $31.7 Million	208,500 Added 1521.9%	222,200 $92,000
Q1 2019 May 10, 2019	BUY	$106.67 - $151.68 $64,002 - $91,008	600 Added 4.58%	13,700 $123,000
Q4 2018 Feb 12, 2019	SELL	$97.32 - $148.76 $447,671 - $684,296	-4,600 Reduced 25.99%	13,100 $181,000
Q3 2018 Nov 09, 2018	SELL	$115.31 - $161.51 $426,647 - $597,587	-3,700 Reduced 17.29%	17,700 $74,000
Q2 2018 Aug 13, 2018	BUY	$71.74 - $153.69 $1.54 Million - $3.29 Million	21,400 New	21,400 $352,000

528

84.2M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.1B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.